CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 263 enrolled
Drug / intervention
modified-ETDRS photocoagulation +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00071773
NCT00071773Phase 2Completed
CompareCT.gov

A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema

Jaeb Center for Health Research·interventional·Posted Nov 3, 2003·Updated Aug 26, 2016

In Brief

A Phase 2 clinical trial evaluating modified-ETDRS photocoagulation and Mild Macular Grid photocoagulation for Diabetic Macular Edema. Completed, enrolled 263 participants.

Detailed Summary

This pilot study will compare the use of current laser treatment for diabetic macular edema with a similar laser treatment that is milder in intensity, but more extensive.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Macular Edema
Countries--
CollaboratorsNational Eye Institute (NEI)

Timeline

Phase 2CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 3, 2003
Enrollment StartJul 1, 2003
Primary CompletionNov 1, 2005
Study CompletionFeb 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 22.7 years ago

Interventions

modified-ETDRS photocoagulationprocedure

A treatment session can be given in single or multiple sittings at the investigator's discretion, as long as the entire treatment session is completed within 6 weeks. Retreatment in Phase 1 of the study should only occur at the 3.5 and 8 month visits.

Mild Macular Grid photocoagulationprocedure

A treatment session can be given in single or multiple sittings at the investigator's discretion, as long as the entire treatment session is completed within 6 weeks. Retreatment in Phase 1 of the study should only occur at the 3.5 and 8 month visits.